Predicting Response to Capecitabine in Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: capecitabine|OTHER: laboratory biomarker analysis|OTHER: pharmacological study
Sponsor: Centre Antoine Lacassagne